Inspire Medical Systems, Inc. is a medical technology company. The Company is focused on the development and commercialization of advanced, minimally invasive solutions for patients with obstructive sleep apnea (OSA). Its proprietary Inspire therapy is FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. It has developed a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The Company sells its Inspire system to hospitals and ambulatory surgery centers (ASCs) in the United States (U.S.) and in select countries in Europe and Japan through a direct sales organization and sells its Inspire system in Singapore and Hong Kong through distributors. Its direct sales force engages in sales efforts and promotional activities focused on ear, nose and throat (ENT) physicians and sleep centers.
企業コードINSP
会社名Inspire Medical Systems Inc
上場日May 03, 2018
最高経営責任者「CEO」Herbert (Timothy P)
従業員数1246
証券種類Ordinary Share
決算期末May 03
本社所在地5500 Wayzata Blvd Ste 1600
都市GOLDEN VALLEY
証券取引所NASDAQ OMX NASDAQ Basic NYSE
国United States of America
郵便番号55416-1237
電話番号17639575037
ウェブサイトhttps://www.inspiresleep.com/
企業コードINSP
上場日May 03, 2018
最高経営責任者「CEO」Herbert (Timothy P)
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし